Cited by 1,182Autophagy in Disease and TherapyUbiquitin and proteasome pathwaysCell death mechanisms and regulation

Autophagy in malignant transformation and cancer progression

Open access
Galluzzi, Lorenzo, Pietrocola, Federico, Bravo‐San Pedro, José Manuel, Amaravadi, Ravi K, Baehrecke, Eric H, Cecconi, Francesco, Codogno, Patrice, Debnath, Jayanta +16 more·2015·The EMBO Journal

Abstract

Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells, such a homeostatic activity constitutes a robust barrier against malignant transformation. Accordingly, many oncoproteins inhibit, and several oncosuppressor proteins promote, autophagy. Moreover, autophagy is required for optimal anticancer immunosurveillance. In neoplastic cells, however, autophagic responses constitute a means to cope with intracellular and environmental stress, thus favoring tumor progression. This implies that at least in some cases, oncogenesis proceeds along with a temporary inhibition of autophagy or a gain of molecular functions that antagonize its oncosuppressive activity. Here, we discuss the differential impact of autophagy on distinct phases of tumorigenesis and the implications of this concept for the use of autophagy modulators in cancer therapy.

Integrity signals

Registry

Crossref · 10.15252/embj.201490784

Cites

283 of 283 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Proficient autophagic responses most often mediate cytoprotective rather than cytotoxic effects in adaptation to stress.

    “Proficient autophagic responses (which are under tight transcriptional and post-translational regulation) [509 799–805] most often operate at the hub of adaptation to stress, hence mediating cytoprotective (rather than cytotoxic) effects [806–811].”
  • Total inhibition of autophagy by tissue-specific knockout of Atg5 or Atg7 accelerates lung cancer oncogenesis driven by Kras G12D, especially with p53 deletion.

    “Moreover, total inhibition of autophagy by tissue-specific knockout of Atg5 or Atg7 accelerates lung cancer oncogenesis driven by Kras G12D , especially in the context of p53 deletion.151”

    From Meta-hallmarks of aging and cancer (2023) · cites this paper as [151]

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., Kimmelman, A., Kumar, S., Levine, B., Maiuri, M. C., Martin, S. J., Penninger, J., Piacentini, M., Rubinsztein, D. C., Simon, H., Simonsen, A., Thorburn, A. M., Velasco, G., Ryan, K. M., & Kroemer, G.
Affiliations
  • Inserm (FR)
  • Abramson Cancer Center (US)
  • University of Massachusetts Chan Medical School (US)
  • University of Rome Tor Vergata (IT)
  • Centre National de la Recherche Scientifique (FR)
  • University of California, San Francisco (US)
  • Virginia Commonwealth University (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • Dana-Farber Cancer Institute (US)
  • University of South Australia (AU)
  • Howard Hughes Medical Institute (US)
  • Institute of Molecular Biotechnology (AT)
  • University of Cambridge (GB)
  • University of Bern (CH)
  • University of Oslo (NO)
  • University of Colorado Anschutz (US)
  • Universidad Complutense de Madrid (ES)
  • Cancer Research UK Scotland Institute (GB)
Corresponding author
Galluzzi, Lorenzo
Venue
The EMBO Journal
Published
2015-02-23
Volume
34
Issue
7
Pages
856-880
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2045122835
Cited by
1,182
References
283
Citations by year
2026: 37 · 2025: 57 · 2024: 67 · 2023: 94 · 2022: 80 · 2021: 125 · 2020: 156 · 2019: 128 · 2018: 116 · 2017: 126 · 2016: 141 · 2015: 54
FWCI
18.99
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
Funders
  • Agence National de la Recherche
  • Association pour la recherche sur le cancer
  • Cancéropôle Ile‐de‐France
  • Institut National du Cancer
  • Fondation Bettencourt‐Schueller
  • Fondation de France
  • Fondation pour la Recherche Médicale
  • European Commission
  • European Research Council
  • LabEx Immuno‐Oncology
  • SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination
  • SIRIC Cancer Research and Personalized Medicine
  • Paris Alliance of Cancer Research Institutes
  • American Cancer Society
  • Institutional Research Grant (IRG‐14‐192‐40)
  • National Health and Medical Research Council of Australia Project Grant (1041807)
  • Senior Principal Research Fellowship (1002863)
  • Ministry of Health of Italy
  • Associazione Italiana per la Ricerca sul Cancro
  • Swiss National Science Foundation
  • Swiss Cancer League
  • Spanish Ministry of Economy and Competitiveness
  • Fondo Europeo de Desarrollo Regional (PI12/02248, FR2009‐0052, IT2009‐0053)
  • Fundación Mutua Madrileña (AP101042012)
  • Fundació La Marató de TV3 (20134031)
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
autophagy, malignant transformation, tumor progression, carcinogenesis, oncoprotein, cellular homeostasis, autophagy modulators, cancer therapy
MeSH terms
Animals, Autophagy, Cell Transformation, Neoplastic, Humans, Neoplasms, Tumor Escape, Tumor Suppressor Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review